Home 
Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.2, p.106-111, 2016
Bratislava Medical Journal 2016 Bratislava Medical Journal Vol.116, No.2, p.106-111, 2016
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.2, p.106-111, 2016 |
||
| Title: Co-administration of cisplatin and curcumin does not alter mood-associated behaviors | ||
| Author: E. A. Demir, M. Oz, M. I. Alp, H. S. Gergerlioglu, K. E. Nurullahoglu Atalik, F. H. Yerlikaya | ||
| Abstract: OBJECTIVES: Cisplatin (cis-diamminedichloroplatinum (II)) is a widely-used platinum-based chemotherapeutic agent which has dose-limiting side-effects. Also, the drug resistance is another instance that decreases treatment success in cisplatin chemotherapy. The growing body of evidence suggests that curcumin, a polyphenolic compound extracted from the spice turmeric, may exert synergistic effects and sensitize malign cells to cisplatin, while alleviating cytotoxicity-related side-effects. The present study was aimed to investigate mood-associated interactions between cisplatin and curcumin. MATERIALS AND METHODS: Thirty-four adult male Wistar albino rats were randomly assigned to four groups as control, curcumin (300 mg/kg/day, p.o. for 5 weeks), cisplatin (5 mg/kg/week, i.p. for 5 weeks), and curcumin plus cisplatin (same doses as above). The open field, elevated plus maze, and forced swim tests were engaged to evaluate mood-associated behaviors. RESULTS: We demonstrated that depression- and anxiety-like behaviors were not altered by the administration of curcumin along with the chronic cisplatin treatment. CONCLUSION: According to the results of the present study, we concluded that curcumin might be regarded as a safe adjuvant in cisplatin chemotherapy in terms of the mood-associated behaviors (Fig. 4, Ref. 41). |
||
| Keywords: cisplatin, curcumin, depression, anxiety; locomotion, exploration | ||
| Published online: 24-Jan-2016 | ||
| Year: 2016, Volume: 116, Issue: 2 | Page From: 106, Page To: 111 | |
| doi:10.4149/BLL_2016_021 |
||
|
|
 download file |
|